Narrative ReviewDiarrhea During COVID-19 Infection: Pathogenesis, Epidemiology, Prevention, and Management
Keywords
Abbreviations used in this paper
Cited by (0)
Conflicts of interest These authors disclose the following: Daniel C. Baumgart has served as scientific consultant and advisory board member for AbbVie, MSD, Janssen, Takeda, Boehringer-Ingelheim, and Amgen. Silvio Danese has served as a speaker, consultant, and advisory board member for Schering-Plough, AbbVie, Actelion, Alphawasserman, AstraZeneca, Cellerix, Cosmo Pharmaceuticals, Ferring, Genentech, Grunenthal, Johnson and Johnson, Millenium Takeda, MSD, Nikkiso Europe GmbH, Novo Nordisk, Nycomed, Pfizer, Pharmacosmos, UCB Pharma, and Vifor. Laurent Peyrin-Biroulet has served as a speaker, consultant, and advisory board member for Merck, AbbVie, Janssen, Genentech, Mitsubishi, Ferring, Norgine, Tillots, Vifor, Hospira/Pfizer, Celltrion, Takeda, Biogaran, Boerhinger-Ingelheim, Lilly, HAC-Pharma, Index Pharmaceuticals, Amgen, Sandoz, Forward Pharma GmbH, Celgene, Biogen, Lycera, Samsung Bioepis, and Theravance. The other author discloses no conflicts.
- a
These authors contributed equally.